Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Botulinum toxin for conditions of the female pelvis: comment.

Israfil-Bayli F, Burton C, Parsons M, Bulchandani S, Toozs-Hobson P.

Int Urogynecol J. 2013 Aug;24(8):1417. doi: 10.1007/s00192-013-2096-9. Epub 2013 May 14. No abstract available.

PMID:
23670164
2.

Botulinum toxin for conditions of the female pelvis.

El-Khawand D, Wehbe S, Whitmore K.

Int Urogynecol J. 2013 Jul;24(7):1073-81. doi: 10.1007/s00192-012-2035-1. Epub 2013 Jan 24. Review.

PMID:
23344218
3.

[Botulinum toxin in urology].

Gamé X, Karsenty G.

Prog Urol. 2006 Nov;16(4 Suppl FMC):24-7. Review. French. No abstract available.

PMID:
17183968
4.

Botulinum toxin: the overall cure for defective relaxation?

Thumshirn M, Fried M.

Endoscopy. 1999 Jun;31(5):392-7. Review. No abstract available.

PMID:
10433051
5.

Botulinum toxin in the management of bowel and bladder function in spinal cord injury and other neurologic disorders.

Dykstra DD.

Phys Med Rehabil Clin N Am. 2003 Nov;14(4):793-804, vi. Review.

PMID:
14580038
6.

Ischiorectal fossa abscess after pelvic floor injection of botulinum toxin.

Brueseke TJ, Lane FL.

Am J Obstet Gynecol. 2012 Mar;206(3):e7-8. doi: 10.1016/j.ajog.2011.12.023. Epub 2011 Dec 27.

PMID:
22381609
7.

[Botulinum toxins for pain].

Soinila S, Haanpää M.

Duodecim. 2011;127(22):2425-30. Review. Finnish.

PMID:
22238920
8.

Botulinum toxin treatment of urethral and bladder dysfunction.

Chuang YC, Smith CP, Somogyi GT, Chancellor MB.

J Formos Med Assoc. 2003 Jan;102(1):5-11. Review.

PMID:
12684605
9.

Botulinum toxin in the management of lower urinary tract dysfunction: contemporary update.

Cruz F, Silva C.

Curr Opin Urol. 2004 Nov;14(6):329-34. Review.

PMID:
15626874
10.

Botulinum toxin for the treatment of lower urinary tract symptoms: a review.

Sahai A, Khan M, Fowler CJ, Dasgupta P.

Neurourol Urodyn. 2005;24(1):2-12. Review.

PMID:
15578628
11.

Botulinum toxin for spastic GI disorders.

Brisinda G, Maria G.

Gastrointest Endosc. 2003 Sep;58(3):472-3. No abstract available.

PMID:
14528238
12.

Emerging role of botulinum toxin in the management of voiding dysfunction.

Smith CP, Chancellor MB.

J Urol. 2004 Jun;171(6 Pt 1):2128-37. Review.

PMID:
15126771
13.

Botulinum toxin: new option for refractory lower urinary tract symptoms in women.

Rickey LM, Kenton K.

Clin Obstet Gynecol. 2008 Mar;51(1):176-86. doi: 10.1097/GRF.0b013e3181621fd2. Review.

PMID:
18303512
14.

[Applications of botulin].

Lindberg L, Kanerva M, Pitkäranta A, Ansaranta M, Ylitalo L, Aaltonen LM, Pakarinen M, Salmenkylä S.

Duodecim. 2011;127(22):2431-43. Review. Finnish.

PMID:
22238921
15.

[Use of botulinum toxin in the treatment of lower urinary tract disorders. Current status. Editorial comment].

Bustamante Alarma S.

Arch Esp Urol. 2010 Dec;63(10):842-3. Spanish. No abstract available.

PMID:
21187565
16.

The use of botulinum toxin in the treatment of refractory overactive bladder.

Mucksavage P, Smith AL, Moy ML.

Ostomy Wound Manage. 2006 Dec;52(12):28, 30, 32-3. Review. No abstract available.

PMID:
17219700
17.

Treatment of intractable tardive lingual dyskinesia with botulinum toxin.

Beckmann YY, Seçil Y, Saka S, Kuserli A, Çiftçi Y.

J Clin Psychopharmacol. 2011 Apr;31(2):250-1. doi: 10.1097/JCP.0b013e31820f4f70. No abstract available.

PMID:
21364341
18.

[The use of botulinum toxin in otorhinolaryngology--experiences and outlook].

Laskawi R.

Laryngorhinootologie. 1997 Nov;76(11):656-9. German. No abstract available.

PMID:
9517972
19.

Guidelines for the therapeutic use of botulinum toxin in movement disorders.

Pagni CA.

Ital J Neurol Sci. 1998 Jun;19(3):189-90. No abstract available.

PMID:
10933476
20.

Dystonias and botulinum toxin.

Khadilkar SV.

J Assoc Physicians India. 2003 May;51:443-4. No abstract available.

PMID:
12974422

Supplemental Content

Support Center